Prurigo Nodularis: Nemolizumab Efficacy Persists at 52 Weeks
San Diego — Nemolizumab, the first-in-class inhibitor of interleukin-31 (IL-31), a neuroimmune cytokine linked to the promotion of pruritis and ...
Read more
Tag: Prurigo
The Earth News is an independent English-language daily published Website from all around the World News